Literature DB >> 19376196

A comparison of model-based (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL/6J mouse.

Z C Baquet1, D Williams, J Brody, R J Smeyne.   

Abstract

The substantia nigra pars compacta (SNpc) is a compact brain structure that contains a variable distribution of cells in both medial to lateral and rostral to caudal dimensions. The SNpc is the primary brain structure affected in Parkinson's disease, where loss of dopaminergic neurons is one of the major hallmarks of the disorder. Neurotoxic and genetic models of Parkinson's disease, as well as mechanisms to treat this disorder, are modeled in the mouse. To accurately assess the validity of a model, one needs to be assured that the method(s) of analysis is accurate. Here, we determined the total number of dopaminergic neurons in the SNpc of the C57BL/6J mouse by serial reconstruction then compared that value to estimates derived using model-based stereology and design-based stereology. Serial reconstruction of the SNpc revealed the total number of SNpc dopaminergic neurons to be 8305+/-540 (+/-SEM). We compared this empirically derived neuron number to model based and design-based stereological estimates. We found that model based estimates gave a value of 8002+/-91 (+/-SEM) while design-based estimates were 8716+/-338 (+/-SEM). Statistical analysis showed no significant difference between estimates generated using model- or design-based stereological methods compared to empirically-derived counts using serial reconstruction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19376196      PMCID: PMC2705113          DOI: 10.1016/j.neuroscience.2009.04.031

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  65 in total

Review 1.  The last decade in Parkinson's disease research. Basic sciences.

Authors:  S Przedborski; M Vila
Journal:  Adv Neurol       Date:  2001

2.  Glia cell number modulates sensitivity to MPTP in mice.

Authors:  Michelle Smeyne; Yun Jiao; Kennie R Shepherd; Richard J Smeyne
Journal:  Glia       Date:  2005-11-01       Impact factor: 7.452

Review 3.  Animal models of Parkinson's disease in rodents induced by toxins: an update.

Authors:  E C Hirsch; G Höglinger; E Rousselet; T Breidert; K Parain; J Feger; M Ruberg; A Prigent; C Cohen-Salmon; J M Launay
Journal:  J Neural Transm Suppl       Date:  2003

4.  Estimators of the number of objects per area unbiased by edge effects.

Authors:  H J Gundersen
Journal:  Microsc Acta       Date:  1978-11

5.  Injection of 6-hydroxydopamine in the substantia nigra of the rat. I. Morphological study.

Authors:  C Sotelo; F Javoy; Y Agid; J Glowinski
Journal:  Brain Res       Date:  1973-08-30       Impact factor: 3.252

6.  GSTpi expression mediates dopaminergic neuron sensitivity in experimental parkinsonism.

Authors:  Michelle Smeyne; Justin Boyd; Kennie Raviie Shepherd; Yun Jiao; Brooks Barnes Pond; Matthew Hatler; Roland Wolf; Colin Henderson; Richard Jay Smeyne
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

7.  Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration.

Authors:  A L McCormack; J G Atienza; J W Langston; D A Di Monte
Journal:  Neuroscience       Date:  2006-05-04       Impact factor: 3.590

Review 8.  Anxiety disorders in Parkinson's disease.

Authors:  Irene H Richard
Journal:  Adv Neurol       Date:  2005

Review 9.  Genetic mouse models of parkinsonism: strengths and limitations.

Authors:  Sheila M Fleming; Pierre-Olivier Fernagut; Marie-Françoise Chesselet
Journal:  NeuroRx       Date:  2005-07

10.  Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype.

Authors:  Mona Thiruchelvam; Alison McCormack; Eric K Richfield; Raymond B Baggs; A William Tank; Donato A Di Monte; Deborah A Cory-Slechta
Journal:  Eur J Neurosci       Date:  2003-08       Impact factor: 3.386

View more
  66 in total

1.  Exercise protects against MPTP-induced neurotoxicity in mice.

Authors:  Kimberly M Gerecke; Yun Jiao; Amar Pani; Vishwajeeth Pagala; Richard J Smeyne
Journal:  Brain Res       Date:  2010-01-29       Impact factor: 3.252

2.  Inflammatory effects of highly pathogenic H5N1 influenza virus infection in the CNS of mice.

Authors:  Haeman Jang; David Boltz; Jennifer McClaren; Amar K Pani; Michelle Smeyne; Ane Korff; Robert Webster; Richard Jay Smeyne
Journal:  J Neurosci       Date:  2012-02-01       Impact factor: 6.167

3.  Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration.

Authors:  Haeman Jang; David Boltz; Katharine Sturm-Ramirez; Kennie R Shepherd; Yun Jiao; Robert Webster; Richard J Smeyne
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

4.  Effects of treadmill exercise on behavioral recovery and neural changes in the substantia nigra and striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse.

Authors:  Beth A Smith; Natalie R S Goldberg; Charles K Meshul
Journal:  Brain Res       Date:  2011-03-21       Impact factor: 3.252

5.  Effects of sleep disruption on stress, nigrostriatal markers, and behavior in a chronic/progressive MPTP male mouse model of parkinsonism.

Authors:  Mo Xu; Jerry K Bohlen; Cynthia Moore; Michelle A Nipper; Deborah A Finn; Carolyn E Jones; Miranda M Lim; Charles K Meshul
Journal:  J Neurosci Res       Date:  2019-09-18       Impact factor: 4.164

6.  Glial cell line-derived neurotrophic factor partially ameliorates motor symptoms without slowing neurodegeneration in mice with respiratory chain-deficient dopamine neurons.

Authors:  Fredrik H Sterky; Karin Pernold; Brandon K Harvey; Eva Lindqvist; Barry J Hoffer; Lars Olson
Journal:  Cell Transplant       Date:  2012-10-08       Impact factor: 4.064

7.  Novel para-phenyl substituted diindolylmethanes protect against MPTP neurotoxicity and suppress glial activation in a mouse model of Parkinson's disease.

Authors:  Briana R De Miranda; Katriana A Popichak; Sean L Hammond; James A Miller; Stephen Safe; Ronald B Tjalkens
Journal:  Toxicol Sci       Date:  2014-11-17       Impact factor: 4.849

8.  Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide.

Authors:  Eric E Beier; Matthew Neal; Gelerah Alam; Melissa Edler; Long-Jun Wu; Jason R Richardson
Journal:  Neurobiol Dis       Date:  2017-08-18       Impact factor: 5.996

9.  Temporal-Spatial Profiling of Pedunculopontine Galanin-Cholinergic Neurons in the Lactacystin Rat Model of Parkinson's Disease.

Authors:  Joanna L Elson; Rafael Kochaj; Richard Reynolds; Ilse S Pienaar
Journal:  Neurotox Res       Date:  2017-12-07       Impact factor: 3.911

10.  G2019S LRRK2 and aging confer susceptibility to proteasome inhibitor-induced neurotoxicity in nigrostriatal dopaminergic system.

Authors:  Qian Xiao; Suosuo Yang; Weidong Le
Journal:  J Neural Transm (Vienna)       Date:  2015-08-08       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.